Keywords: biogen, idec, co-develop, cardiokine, lixivaptan, drugmakers, signed

Biogen Idec to co-develop Cardiokine's lixivaptan

Article | 09 July 2007

Print This

US drugmakers Biogen Idec and Cardiokine have signed an agreement to jointly develop lixivaptan, an oral compound expected to enter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in